Last update 08 May 2025

Diprophylline/Papaverine Hydrochloride/Diphenhydramine Hydrochloride/Ephedrine Hydrochloride/Ephedrine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Asthphyllin, アストフィリン
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesInfectious DiseasesRespiratory Diseases
Active Indication
Acute BronchitisAsthmaAsthmatic bronchitis+ [1]
Inactive Indication-
Originator Organization
Alfresa Pharma Corp.Alfresa Pharma Corp.
Active Organization
Alfresa Pharma Corp.Alfresa Pharma Corp.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (08 May 1952),
Acute BronchitisAsthmaAsthmatic bronchitis+ [1]
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H22ClNO4
InChIKeyUOTMYNBWXDUBNX-UHFFFAOYSA-N
CAS Registry61-25-6
View All Structures (5)

Related

100 Clinical Results associated with Diprophylline/Papaverine Hydrochloride/Diphenhydramine Hydrochloride/Ephedrine Hydrochloride/Ephedrine
Login to view more data
100 Translational Medicine associated with Diprophylline/Papaverine Hydrochloride/Diphenhydramine Hydrochloride/Ephedrine Hydrochloride/Ephedrine
Login to view more data
100 Patents (Medical) associated with Diprophylline/Papaverine Hydrochloride/Diphenhydramine Hydrochloride/Ephedrine Hydrochloride/Ephedrine
Login to view more data
100 Deals associated with Diprophylline/Papaverine Hydrochloride/Diphenhydramine Hydrochloride/Ephedrine Hydrochloride/Ephedrine
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute Bronchitis
Japan
Alfresa Pharma Corp.Alfresa Pharma Corp.
08 May 1952
Asthma
Japan
Alfresa Pharma Corp.Alfresa Pharma Corp.
08 May 1952
Asthmatic bronchitis
Japan
Alfresa Pharma Corp.Alfresa Pharma Corp.
08 May 1952
Bronchitis, Chronic
Japan
Alfresa Pharma Corp.Alfresa Pharma Corp.
08 May 1952
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free